Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

711

Participants

Timeline

Start Date

August 10, 2016

Primary Completion Date

August 19, 2017

Study Completion Date

March 30, 2018

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

semaglutide

Oral semaglutide once-daily.

DRUG

liraglutide

Subcutaneous (s.c.) injection once-daily.

DRUG

placebo

Placebo once-daily.

Trial Locations (108)

24

Novo Nordisk Investigational Site, Umm Al Quwain City

1032

Novo Nordisk Investigational Site, Budapest

1042

Novo Nordisk Investigational Site, Budapest

1501

Novo Nordisk Investigational Site, Benoni

2193

Novo Nordisk Investigational Site, Johannesburg

2800

Novo Nordisk Investigational Site, Tatabánya

2951

Novo Nordisk Investigational Site, Al Mafraq

4092

Novo Nordisk Investigational Site, Durban

4450

Novo Nordisk Investigational Site, Durban

4545

Novo Nordisk Investigational Site, Dubai

5004

Novo Nordisk Investigational Site, Szolnok

5700

Novo Nordisk Investigational Site, Gyula

6300

Novo Nordisk Investigational Site, Kalocsa

7500

Novo Nordisk Investigational Site, Cape Town

7900

Novo Nordisk Investigational Site, Szigetvár

8000

Novo Nordisk Investigational Site, Székesfehérvár

8800

Novo Nordisk Investigational Site, Nagykanizsa

10000

Novo Nordisk Investigational Site, Zagreb

11501

Novo Nordisk Investigational Site, Mineola

12203

Novo Nordisk Investigational Site, Albany

14612

Novo Nordisk Investigational Site, Falkensee

15317

Novo Nordisk Investigational Site, McMurray

21010

Novo Nordisk Investigational Site, Vinnytsia

21499

Novo Nordisk Investigational Site, Ajman

22607

Novo Nordisk Investigational Site, Hamburg

23219

Novo Nordisk Investigational Site, Richmond

23454

Novo Nordisk Investigational Site, Virginia Beach

23606

Novo Nordisk Investigational Site, Newport News

23758

Novo Nordisk Investigational Site, Oldenburg I. Holst

27408

Novo Nordisk Investigational Site, Greensboro

28401

Novo Nordisk Investigational Site, Wilmington

28655

Novo Nordisk Investigational Site, Morganton

29485

Novo Nordisk Investigational Site, Summerville

32256

Novo Nordisk Investigational Site, Jacksonville

32801

Novo Nordisk Investigational Site, Orlando

32804

Novo Nordisk Investigational Site, Orlando

33009

Novo Nordisk Investigational Site, Hallandale

33155

Novo Nordisk Investigational Site, Miami

33401

Novo Nordisk Investigational Site, West Palm Beach

33713

Novo Nordisk Investigational Site, St. Petersburg

34470

Novo Nordisk Investigational Site, Ocala

34555

Novo Nordisk Investigational Site, Rahba City

35222

Novo Nordisk Investigational Site, Birmingham

43016

Novo Nordisk Investigational Site, Dublin

43537

Novo Nordisk Investigational Site, Maumee

44791

Novo Nordisk Investigational Site, Bochum

47000

Novo Nordisk Investigational Site, Karlovac

47051

Novo Nordisk Investigational Site, Duisburg

54701

Novo Nordisk Investigational Site, Náchod

59701

Novo Nordisk Investigational Site, Butte

61603

Novo Nordisk Investigational Site, Peoria

65059

Novo Nordisk Investigational Site, Odesa

66386

Novo Nordisk Investigational Site, Saint Ingbert-Oberwürzbach

66606

Novo Nordisk Investigational Site, Topeka

67059

Novo Nordisk Investigational Site, Ludwigshafen

73069

Novo Nordisk Investigational Site, Norman

75230

Novo Nordisk Investigational Site, Dallas

76180

Novo Nordisk Investigational Site, North Richland Hills

78048

Novo Nordisk Investigational Site, Villingen-Schwenningen

78229

Novo Nordisk Investigational Site, San Antonio

78249

Novo Nordisk Investigational Site, San Antonio

80246

Novo Nordisk Investigational Site, Denver

90720

Novo Nordisk Investigational Site, Los Alamitos

92111

Novo Nordisk Investigational Site, San Diego

32174-6302

Novo Nordisk Investigational Site, Ormond Beach

70461-4231

Novo Nordisk Investigational Site, Slidell

03756

Novo Nordisk Investigational Site, Lebanon

07666

Novo Nordisk Investigational Site, Teaneck

37620-7352

Novo Nordisk Investigational Site, Bristol

76012-4637

Novo Nordisk Investigational Site, Arlington

75390-9302

Novo Nordisk Investigational Site, Dallas

77004-7000

Novo Nordisk Investigational Site, Houston

31 000

Novo Nordisk Investigational Site, Osijek

35 000

Novo Nordisk Investigational Site, Slavonski Brod

10 000

Novo Nordisk Investigational Site, Zagreb

304 60

Novo Nordisk Investigational Site, Pilsen

150 00

Novo Nordisk Investigational Site, Prague

H-6725

Novo Nordisk Investigational Site, Szeged

113-8655

Novo Nordisk Investigational Site, Bunkyo-ku, Tokyo

862 0976

Novo Nordisk Investigational Site, Kumamoto-shi,Kumamoto

310-0826

Novo Nordisk Investigational Site, Mito-shi, Ibaraki

831-0016

Novo Nordisk Investigational Site, Okawa-shi, Fukuoka

060-0001

Novo Nordisk Investigational Site, Sapporo-shi, Hokkaido

329-0433

Novo Nordisk Investigational Site, Shimotsuke-shi, Tochigi

564-0051

Novo Nordisk Investigational Site, Suita-shi, Osaka

323-0022

Novo Nordisk Investigational Site, Tochigi

242-0004

Novo Nordisk Investigational Site, Yamato-shi, Kanagawa

LV-5001

Novo Nordisk Investigational Site, Ogre

LV-1002

Novo Nordisk Investigational Site, Riga

LV-1011

Novo Nordisk Investigational Site, Riga

LV-1038

Novo Nordisk Investigational Site, Riga

15-445

Novo Nordisk Investigational Site, Bialystok

85-822

Novo Nordisk Investigational Site, Bydgoszcz

80-214

Novo Nordisk Investigational Site, Gdansk

88-140

Novo Nordisk Investigational Site, Gniewkowo

30-363

Novo Nordisk Investigational Site, Krakow

60-589

Novo Nordisk Investigational Site, Poznan

70-506

Novo Nordisk Investigational Site, Szczecin

02-507

Novo Nordisk Investigational Site, Warsaw

52-416

Novo Nordisk Investigational Site, Wroclaw

00949

Novo Nordisk Investigational Site, Toa Baja

08501

Novo Nordisk Investigational Site, Bardejov

851 01

Novo Nordisk Investigational Site, Bratislava

040 01

Novo Nordisk Investigational Site, Košice

949 01

Novo Nordisk Investigational Site, Nitra

04801

Novo Nordisk Investigational Site, Rožňava

038 61

Novo Nordisk Investigational Site, Vrútky

04114

Novo Nordisk Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT02863419 - Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter